AKT1 and neoplasm: This prediction was rigorously verified by Western blot experiments: IPTF can specifically inhibit the activation of key phosphorylation sites of AKT (Ser473), EGFR (Tyr1068), and ERK (Tyr204), thereby synergistically blocking the malignant proliferation process of tumor cells.